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Brucella is responsible for brucellosis, one of the most common zoonoses worldwide that causes important economic losses in
several countries. Increasing evidence indicates that adhesion of Brucella spp. to host cells is an important step to establish infec-
tion. We have previously shown that the BmaC unipolar monomeric autotransporter mediates the binding of Brucella suis to
host cells through cell-associated fibronectin. Our genome analysis shows that the B. suis genome encodes several additional
potential adhesins. In this work, we characterized a predicted trimeric autotransporter that we named BtaE. By expressing btaE
in a nonadherent Escherichia coli strain and by phenotypic characterization of a B. suisbtaEmutant, we showed that BtaE is
involved in the binding of B. suis to hyaluronic acid. The B. suisbtaEmutant exhibited a reduction in the adhesion to HeLa
and A549 epithelial cells compared with the wild-type strain, and it was outcompeted by the wild-type strain in the binding to
HeLa cells. The knockout btaEmutant showed an attenuated phenotype in the mouse model, indicating that BtaE is required for
full virulence. BtaE was immunodetected on the bacterial surface at one cell pole. Using old and new pole markers, we observed
that both the BmaC and BtaE adhesins are consistently associated with the new cell pole, suggesting that, in Brucella, the new
pole is functionally differentiated for adhesion. This is consistent with the inherent polarization of this bacterium, and its role in
the invasion process.
Brucella species are responsible for brucellosis, one of the mostwidespread zoonotic diseases in the world that affects a range
of different mammals. Currently, there are 10 recognized species
of Brucella, based on host preferences, pathogenicity, and other
phenotypic differences. Brucellosis remains endemic in most ar-
eas of the world; several animal species with agricultural relevance
are susceptible to the disease, and there are also wildlife reservoirs
of Brucella, which makes eradication more complicated (1). In
particular, Brucella abortus, Brucella melitensis, and Brucella suis
are themost economically significant pathogens of the group.Hu-
manbrucellosis is caused by accidental contaminationwith repro-
ductive ormammary secretions from infected animals (2, 3) and is
characterized by a strong undulating fever, which, if untreated,
may lead to a chronic stage of the disease and the appearance of
serious complications such as endocarditis, osteoarthritis, and
neurological disorders (3).
The preferred niche of Brucella is intracellular; when brucellae
are ingested or inhalated, they penetrate through mucosal sur-
faces, and subsequently are transported to the lymph nodes by
macrophages. Brucella spp. are able to infect and survive within
macrophages in a compartment derived from the endoplasmic
reticulum (4–6). It was shown that Brucella also has the ability to
infect a great variety of host cells, including epithelial cells, placen-
tal trophoblasts, neurons, and cells from male and female repro-
ductive tissues, to name a few (6, 7). Brucella has a marked ability
to elude some of the basic mechanisms of the host immune sys-
tem, which partly explains the frequent relapse after treatment
(8, 9).
It was shown that initial adhesion of several pathogens to the
host cell surface is a critical step in the infection process that helps
the pathogens to avoid rapid clearance from host tissues (10).
Several bacterial filamentous or nonpolymeric adhesins have been
shown to participate in the primary interaction with the host cells
as well as with components of the extracellular matrix (ECM)
(11). Cumulative evidence supports the idea that adhesion to the
ECMor to host cells is also an important step forBrucella infection
(12–16). It was proposed that binding of Brucella to the host is
mediated by host molecules containing sialic acid and/or sulfated
residues and by components of the ECM such as fibronectin, col-
lagen, and vitronectin. By phage display, we have recently identi-
fied a unipolar fibronectin-binding protein belonging to the type I
(monomeric) autotransporter family fromB. suis, whichwe called
BmaC (15). Autotransporters are a superfamily of proteins pro-
duced by Gram-negative bacteria that share a domain organiza-
tion composed of an N-terminal functional domain named the
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“passenger” domain and aC-terminal translocator-domain that
exhibits a -barrel structure with a hydrophilic pore. Autotrans-
porters are transported by the Sec complex across the inner mem-
brane, and the -domain subsequently transports the covalently
linked passenger domain across the outermembrane (17). Several
sets of evidence indicated that BmaC is involved in the polar bind-
ing of single bacteria to epithelial cells (15). A comprehensive
bioinformatics search allowed the identification of several addi-
tional putative adhesins or invasins. One such candidate corre-
sponded to a protein named BtaE that is predicted to belong to the
type II (trimeric) autotransporter family. In this work, we show
that BtaE participates in the binding of B. suis to hyaluronic acid
and epithelial cells and is required to achieve full infectivity in the
mouse model. We also analyzed the localization of BtaE on the
bacterial surface and found that it showed unipolar localization,
which has not been previously reported for a trimeric autotrans-
porter (TA). This observation, together with the previous evi-
dence indicating that BmaC also shows unipolar localization (15),
prompted us to determine whether BtaE or BmaC or both are
localized at a particular pole, using markers of the new and old
poles (18–20). Our observations show that BtaE and BmaC are
exclusively associated with the new pole, suggesting that this pole
inBrucella is specialized for adhesion. These data support the con-
cept that bacterial polarity is an important feature of Brucella
physiology.
MATERIALS AND METHODS
Bacterial strains, cell culture, and media. Escherichia coli strains used in
this study (DH5, K-12, and derivatives) were grown at 37°C in Luria-
Bertani (LB)medium. Antibiotics were added when needed: ampicillin at
200 g/ml, chloramphenicol (Cm) at 50 g/ml, and tetracycline at 5
g/ml. Brucella suis M1330 (ATCC 23444) and derivative strains were
grown at 37°C in Bacto tryptic soy broth (TSB; Bacto). When necessary,
antibiotics were added: chloramphenicol at 6 g/ml, kanamycin (Km) at
50 g/ml, and nalidixic acid (Nal) at 10 g/ml. HeLa cells and lung epi-
thelial A549 (ATCCCCL-185) cells were cultured in Dulbecco’s modified
Eagle’s medium (DMEM;Gibco) andmurine J774macrophages in RPMI
(Gibco) media; both were supplemented with 5% fetal calf serum (PAA),
at 37°C in a 5% CO2 atmosphere.
Molecular techniques. All DNA manipulations were carried out by
using standard procedures. Sequencing was done by cycle sequencing
performed with a BigDye kit (Applied Biosystems) in a 3130 Genetic
Analyzer (Applied Biosystems). Sequence data of B. suis were obtained
from The Institute for Genomic Research (TIGR) website (http://www
.tigr.org). PCR primers containing added restriction enzyme sites were
designed to amplify the flanking regions of btaE. Primers F1 (5=-CGGGA
TCCATCGAGTGAGGCAAGAGTC-3=) and R1 (5=-GGCTGCAGCATG
AGATATAATCTCTTAT-3=) amplified a region of 463 bp upstream of
btaE, and primers F2 (5=-CGCTGCAGTGGAGCATAATCCGACCGCA
GC-3=) and R2 (5=-GCGCATGCGTCACACACCAATGTCCAGT-3=)
amplified a region of 332 bp downstreamof the gene. New restriction sites
are underlined. The generated PCR fragments were purified, cleaved with
the corresponding enzymes, ligated together, and cloned into the
pK18mobsacB mobilizable suicide vector (Km resistant) (21), obtaining
pKmobsacbtaE plasmid. This plasmid was conjugated into a nalidixic-
resistant derivative of the wild-type strain B. suis M1330, and double-
recombinant clones were selected (Nalr, Kms, sucrose resistant). The de-
letion of the open reading frame (ORF) was confirmed by PCR and
reverse transcription-PCR (RT-PCR).
To provide a phenotypic confirmation of the B. suis btaEmutant,
the entire btaE gene (including its own promoter) was cloned into a
broad-host-range plasmid. A region of 2,839 bp containing 565 bp of
the upstream region, the entire btaE ORF, and 54 bp corresponding to
the downstream region was amplified using the following primers:
FComp (5=-AGCTCGAGATGCCTGTTACCATGCGCCGCAGCG-3=)
and RComp (5=-CTACTAGTGTCGGATTATGCTCCAAGACTGATCT-
3=). New restriction sites are underlined. The amplified product was
cloned into the pBBR1MCS-1mid-copy-number plasmid (22), obtaining
the pBBRbtaEplasmid,whichwas conjugated into theB. suisbtaE strain.
Complemented clones were selected (Cmr) and confirmed by PCR and
RT-PCR.
E. coli K-12 was transformed with pBBRbtaE or empty pBBR1MCS
vector as a control. Transformed clones were selected (Cmr) and con-
firmed by PCR.
Bioinformatics. To identify putative adhesins, adhesion domains of
characterized adhesins from other bacteria were compared to the entire
Brucella suis 1330 genome using the Protein Motif Search Tool at the J.
Craig Venter Institute Comprehensive Microbial Resource (JCVI CMR).
Domains displayed by each candidate were analyzed with Pfam (23),
BLAST (24), and daTAA (25), which is specific for trimeric autotransport-
ers. Secretion signal was identified with the SignalP Server (26). Align-
ments of the proteins were made with ClustalX (1.81) (27).
Binding to ECM components. Analysis of the affinity of BtaE-ex-
pressing bacteria to extracellular matrix (ECM) components was per-
formed as described elsewhere (28). Briefly, 96-well plates (Nunc Max-
isorp) were coated overnight at 4°C with 50 l of 100 g/ml solutions of
the ligands, dissolved in phosphate-buffered saline (PBS). Bacteria were
grown overnight, washed, and resuspended in PBS to a final concentra-
tion of 1 109CFU/ml (optical density [OD] 1 forE. coli andOD 0.2
for Brucella). Wells were washed three times with 100l PBS to eliminate
unbound ligand. Then, 50 l of bacterial suspensions was added to each
well and incubated at 37°C for 3 h. After incubation, wells were washed
three times with PBS to remove nonadherent bacteria, and then adherent
bacteria were harvested with trypsin-EDTA (0.05% trypsin [Gibco]–
0.5% EDTA [USB]). After incubation for 10 min at 37°C, serial dilutions
were done, followed by plating on LB or TSB agar with the appropriate
antibiotic, and CFU were determined.
Antibodies. Polyclonal antiserum was obtained by immunization of
mice with a peptide corresponding to a portion of the BtaE passenger
domain (Fig. 1, underlined region). The coding sequence was amplified
using the primers FAb (5=-ATCATATGCTGCATGATATTGAAAGTGG
C-3=) and RAb (5=-CTGTCGACTCACGCTTCACCAAGCG-3=) and
cloned into pET28a (Novagen). New restriction sites are underlined. The
recombinant peptide was purified by high-pressure liquid chromatogra-
phy (HPLC) and then used for immunization of 10 C57 male mice. Ani-
mal procedures were performed in compliance with institutional as well
as governmental rules and regulations. Anti-BmaC antibodies were al-
ready used in a previous publication (15).
Western blot analysis. The method used to obtain total membranes
from Brucella strains was based on a protocol previously described (29).
Briefly, 50-ml TSB cultures were harvested, resuspended in 1ml of cold 20
mM Tris-HCl buffer (pH 8.0)–1 mM phenylmethylsulfonyl fluoride
(PMSF), and disrupted using Precellys (Bertin Technologies). The ho-
mogenate was centrifuged twice at 4,700 relative centrifugal force (RCF)
at 4°C for 10 min to remove unbroken cells and Precellys beads, and the
supernatant was ultracentrifuged at 134,000 RCF for 90 min at 4°C. The
pellet was suspended in 1%Sarkosyl (sodium lauroyl sarcosinate)–20mM
HEPES buffer and incubated for 30 min at room temperature, and then
the suspension was centrifuged again at 134,000 RCF for 90 min. The
pellet was resuspended in 300 l 20 mM HEPES buffer, 700 l of formic
acid was added, and the suspension was incubated overnight at room
temperature in darkness. One milliliter of distilled H2O was added, and
the sample was lyophilized. Cracking buffer was used to resuspend the
resulting powder, and the suspension was heated for 10 min at 95°C and
subjected to sodium dodecyl sulfate (SDS)-PAGE. Proteins resolved by
SDS-PAGE were transferred to polyvinylidene difluoride (PDVF) mem-
branes (GE Healthcare) and blocked overnight with Tris-buffered saline
(TBS)–5% (wt/vol) milk powder at 4°C with gentle agitation. Blots were
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probed with polyclonal mouse anti-BtaE serum (1:8,000) and a goat
horseradish peroxidase (HRP)-conjugated secondary anti-mouse anti-
body (1:30,000; Santa Cruz) and then revealed using ECL Plus (Amer-
sham). BtaE antiserum was preadsorbed with E. coli carrying empty
pET28a.
Immunofluorescence analysis. Brucella was transformed with a de-
rivative of pBBR1MCS-2 (30), which carries gfp constitutively expressed
(excitation at 488 nm, emission at 509 nm; filters used a bandpass [BP]
range of 505 to 530 nm) (15). The strains carrying polar markers fused to
fluorescent proteins were obtained as previously described by biparental
conjugation with E. coli S17.1 strains carrying either pdhS-egfp (19) or
aidB-yfp (18).
To detect BtaE on the bacterial surface, 1 ml of a culture of fluorescent
bacteria (green fluorescent protein [GFP]-tagged brucellae) or strains car-
rying either PdhS-enhanced GFP (PdhS-eGFP) or AidB-yellow fluores-
cent protein (AidB-YFP) was refreshed and grown for another hour in
TSB media. The cells were then collected, washed once with PBS, and
incubated with 3.7% paraformaldehyde for 15min at 37°C. The cells were
washed twice with PBS and once with PBS–1% bovine serum albumin
(BSA) and then incubated 30 min with 40 l of anti-BtaE or anti-BmaC
antibodies (diluted 1:50 in PBS containing 0.5% BSA). The cells were
washed again three times with PBS–1% BSA and incubated with 40 l of
IgG-CY3-conjugated donkey anti-mouse antibody preparation (Jackson
ImmunoResearch) and diluted 1:250 in PBS containing 0.5% BSA for 40
min. In the case of the strains carrying the pole markers, DAPI (4=,6=-
diamidino-2-phenylindole) was used to stain the DNA at a 1 g/ml final
concentration simultaneously with the secondary antibody used for the
immunodetection of BtaE or BmaC. After two washes with 1 ml PBS–1%
BSA and one wash with PBS, an aliquot of the cell suspension was
mounted with Mowiol 4-88 (Calbiochem) on a microscope slide, or on
agarose pads. Samples were covered with a coverslip and observed either
with a Carl Zeiss LSM 5 Pascal laser scanning microscope, using a Plan-
Aprochromat 100/1.4 oil differential interference contrast (DIC) objec-
tive, or, in the case of fluorescentmarkers, with a Carl Zeiss LSM510Meta
laser scanning microscope, using a Plan-Apochromat 60/1.4 oil DIC
objective. All incubations were carried out at room temperature.
Cell infection assays. HeLa or A549 (ATCC CCL 185) cells were
seeded in 24-well plates (5  104 cells per well) and inoculated with the
different strains (multiplicity of infection [MOI], 100:1). Plates were cen-
trifuged for 10min at 170 RCF and taken to a 5%CO2 atmosphere at 37°C
for 1 h. To determine the total number of bacteria associated to the cells,
wells were washed three times with PBS and treated for 10 min at 37°C
with 0.1%Triton X-100 (in deionized sterile water). Serial dilutions of the
obtained lysates were done in PBS and plated onTSAwith the appropriate
antibiotics, and CFU were determined. To determine the number of in-
tracellular viable bacteria, a standard gentamicin protection assay was
performed: 1 h postinfection (p.i.), the culture medium was changed to a
fresh one containing 20 g/ml gentamicin to eliminate remaining extra-
cellular bacteria. After 1 h (5% CO2 atmosphere at 37°C), wells were
washed three times with PBS and treated with 0.1% Triton X-100 as pre-
viously described. Lysates were serially diluted and plated on TSAwith the
appropriate antibiotics, and CFU were determined. The number of ad-
herent bacteria was calculated as the difference between the total bacteria
associated to the cells and the intracellular bacteria. All the results were
expressed in reference to the wild-type strain, defined as 100%. For the
inhibition experiment with hyaluronic acid, wild-type or mutant bacteria
were preincubated with different concentrations of hyaluronic acid for 30
min at 37°C and bacterial adhesion to HeLa cells was determined as de-
scribed above.
In the competition assay with the wild-type and mutant strains, the
final MOI was maintained; for that, equal quantities of CFU of each
strain were inoculated (MOI, 50:1 each). In order to determine the
number of intracellular and total bacteria corresponding to each
strain, the wild-type and mutant strains were labeled with different
antibiotic resistances. The wild-type strain was transformed with a
plasmid derivative of pBBR1MCS-2 that confers resistance to kanamy-
cin (Km) (30). On the other hand, the gentamicin resistance (Gmr)
gene from the miniTn7(Gm)PA1/04/03 HcRed-a plasmid (Gm
r Cmr)
(31) was removed by deletion using the PstI and ApaI restrictions sites,
due to international restrictions with respect to antibiotic use for Bru-
cella. The mini-Tn7 HcRed transposon (now Cmr, Gms) was inserted
in the genome of the btaE mutant, generating a Cmr strain (31). Cel-
lular lysates that included the bacteria were plated on TSA with either
Cm or Km to determine the CFU of each strain. Both the wild-type and
btaE B.suis strains, carrying the pBBR1MCS-2 (Kmr) and the
miniTn7 (Cmr), respectively, were shown to grow normally in liquid
or semisolid TSB media.
Virulence in BALB/c mice. Six-to-8-week-old female BALB/c mice
were purchased from the animal facility at Leloir Institute, Argentina.
They were randomly distributed in experimental groups at least 1 week
before being inoculated. The animals were housed in filter-ventilated con-
tainment in the Laboratory Animal Facility of the Facultad de Ciencias
Veterinarias (Tandil, Argentina), receiving water and food ad libitum. All
experimental protocols were performed according to the premise of min-
imizing the suffering to which animals are exposed and using the mini-
mum number of experimental animals to ensure statistically significant
results. Animal procedures and management protocols were approved
by the local Institutional Animal Welfare Committee according to the
Animal Welfare Policy (Act 087/02) of the Faculty of Veterinary
Medicine (Universidad Nacional del Centro de la Provincia de Buenos
Aires [U.N.C.P.B.A.], Tandil, Argentina; http://www.vet.unicen.edu.ar).
BALB/c mice (10 per group) were inoculated by intragastric delivery of
wild-type B. suis 1330 (1.3 108 CFU/mouse), its isogenicbtaEmutant
(1.3 108 CFU/mouse), or the complemented mutant (1.48 108 CFU/
mouse) suspended in 300l of 10% sodiumbicarbonate by use of a plastic
feeding tube introduced through the mouth. Five mice from each group
FIG 1 BtaE domain organization. A schematic representation of BtaE showing the N-terminal signal, the conserved domains, and motifs predicted by
bioinformatics (SignalP, Pfam, and BLAST) is presented. Numbers indicate amino acid positions within BtaE.
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were sacrificed at 7 and 30 days postinfection (p.i.), and spleens were
removed. Dilutions of spleen homogenates were plated in duplicate on
TSA. After 4 days of incubation, CFU were counted and expressed as the
log10 value per spleen. The CFU data were normalized by log transforma-
tion and evaluated by analysis of variance (ANOVA) followed by Dun-
nett’s post hoc test (Prism 5.0; GraphPad Software, Inc.). The experiment
was repeated twice with similar results.
RESULTS
BtaE: a putative adhesin fromthe trimeric autotransporter fam-
ily. Database searches within the NCBI genomic BLAST search
engine showed the presence in the B. suis 1330 genome of 11
predicted ORFs that exhibit one or more conserved domains as-
sociated with adhesion, including BmaC (15). One of these can-
didates (BR0072) is annotated in the B. suis 1330 genome (32) as
an “outermembrane protein” and has a predictedmolecularmass
of 75.45 kDa (740 amino acids). In silico analysis indicated that
BR0072 displays an N-terminal signal peptide (26), a YadA-like
C-terminal region (23), and a sequence of 642 amino acids be-
tween the two regions. The YadA-like and N-terminal regions
(together with a central region or “passenger domain”) are the
characteristic precursor domains of type II trimeric autotrans-
porter (TA) proteins (17, 33, 34); therefore, we named BR0072
BtaE (for Brucella trimeric autotransporter). As mentioned ear-
lier, TAs represent a subfamily of autotransporter proteins, which
are defined by the presence of a distinctive C-terminal transloca-
tor domain that forms a highly stable trimer in the outer mem-
brane (33). The characterized members of the TA subfamily have
been found to mediate bacterial adherence to eukaryotic cells and
components of the extracellular matrix (ECM) (33–35), as YadA
of Yersinia enterocolitica (36) and UspA1 and UspA2 ofMoraxella
catarrhalis (37).
TAs have been found to exhibit similar architectural struc-
tures, consisting of a globular head and a stalk (both correspond-
ing to the passenger domain) and an anchor domain (correspond-
ing to the C-terminal region), similar to a lollipop-shaped
structure (38). To analyze the modular organization, the entire
BtaE sequence was entered into the Domain Annotation of Trim-
eric Autotransporter Adhesins (daTAA) (25). Three regions cor-
responding to the head (amino acids 154 to 222, 254 to 335, and
434 to 529) and four corresponding to the neck (amino acids 223
to 244, 336 to 357, 530 to 551, and 600 to 618) were identified.
Interestingly, in silico analysis using the Pfam protein database
(23) showed that two of the three regions predicted to be part of
the head contain three Hep_Hag repeats, and the neck portions
overlap four noncontiguous HIM repeat motifs (Fig. 1), which
represent potential adhesion motifs. In addition, an anchor do-
main and connectors were also identified. As expected, the anchor
domain matches the YadA-like C-terminal region (Fig. 1).
In vitro binding activities: BtaE is involved in adhesion to
hyaluronic acid. It has been shown that Brucella spp. bind to
components of the ECM, such as fibronectin and collagen. In-
deed, as mentioned earlier, we have recently shown that the type I
autotransporter BmaC protein is involved in the binding of B. suis
to fibronectin (15). On the other hand, there are some examples of
TAs mediating adherence to ECM components (34). In order to
assess the affinity of BtaE for ECM components, we first per-
formed a heterologous approach. The btaE gene was cloned with
its own promoter into the pBBR1MCS vector, and the resulting
plasmid (pBBRbtaE) was transferred into a nonadherent, nonin-
vasive E. coli K-12-derivative strain. Binding of E. coli carrying
pBBRbtaE plasmid or the empty vector to different immobilized
ligands was evaluated. Expression of the BtaE protein in the het-
erologous host was confirmed byWestern blotting (see below). E.
coli pBBRbtaEwas able to bindmore efficiently to hyaluronic acid
(190%  21%) and fibronectin (185%  22%) than the control
strain, which was considered 100% (Fig. 2A). No differences were
observed in the adhesion of the heterologous host expressing BtaE
to collagen or fetuin (a sialic acid-rich protein) (Fig. 2A).
Autotransporters have been shown to mediate a variety of
other functions. For example, YadA of Yersinia enterocolitica par-
ticipates in the binding to hydrophobic abiotic surfaces, in cellular
autoagglutination, and in serum resistance, in addition to adhe-
sion to and invasion of host cells (36). E. coli expressing btaE did
not show any differential phenotype regarding attachment to
FIG 2 Binding of BtaE-expressing bacteria to ECM components. Plastic wells were coated with collagen type I, hyaluronic acid, fetuin, and fibronectin and
subsequently incubatedwith the different strains. After beingwashed, bound bacteria were harvestedwith trypsin-EDTA; then, serial dilutionswere done and the
bacteria were plated on appropriatemedia. (A) E. coli pBBRbtaE and E. coli pBBR1MCS (control strain) were assayed. (B) The wild-type (wt) strain of B. suis and
the B. suis btaE and btaE pBBRbtaE isogenic strains were analyzed. Values correspond to the percentages of total bacteria recovered from the wells after
incubation with reference to the control strain (E. coli pBBR1MCS in panel A and B. suis wt in panel B), to which a value of 100% was assigned. Data represent
the means  standard deviations (SD) of the results of a representative experiment done in triplicate. Three independent experiments were performed with
similar results. Data were analyzed by Student’s t test and by one-way ANOVA followed by a Tukey a posteriori test. *, significantly different from control (P
0.05), with 95% confidence.
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polystyrene or autoagglutination or even resistance to 8% serum
(with complement activity) compared with the control strain
(data not shown).
We next investigated the effect of a btaE deletion on the bind-
ing ofB. suis to the immobilized ligands.No significant differences
between the wild-type and mutant strains were observed in the
binding to collagen, fetuin, or fibronectin. However, the B. suis
btaEmutant showed a significant decrease in its ability to bind to
hyaluronic acid (18% 8%) relative to the wild type (considered
100%). Wild-type binding levels were restored in the mutant
strain complemented with the pBBRbtaE plasmid (Fig. 2B). Thus,
although a contribution of BtaE to the interaction of B. suis with
fibronectin cannot be ruled out, our observations support a role of
BtaE in the binding of B. suis to hyaluronic acid.
The B. suis btaE mutant was not impaired in attachment to
abiotic surfaces or in its ability to autoaggregate in liquid cultures,
and was not more susceptible to 10% or 50% sera (both bovine
and porcine, with complement activity) than the wild-type strain
(data not shown). Hence, taken together, these observations sug-
gest that, unlike other trimeric autotransporters, BtaE is not in-
volved in any of these activities.
BtaEparticipates in the adhesion ofB. suis to host cells and is
required for full virulence inmice.Toanalyze the contributionof
BtaE to the interaction ofB. suiswith host cells, the ability of theB.
suis btaE mutant to adhere to and invade HeLa cells (human
epithelial carcinoma cell line) was compared with that of the wild-
type strain. Cells were seeded in multiwell plates and inoculated
with the different strains for 1 h. To determine the total number of
cell-associated bacteria, cells were lysed with a nonionic detergent
andCFUwere determined by plating serial dilutions of cell lysates.
To determine the number of intracellular viable bacteria, a stan-
dard gentamicin protection assay was performed. The number of
adherent bacteria was calculated as the difference between total
cell-associated and intracellular bacteria. B. suis btaE showed a
significant reduction (by 63%  7%) in the ability to adhere to
HeLa cells compared to the wild-type strain (Fig. 3A) as well as a
decrease (by 70%  14%) in the ability to invade these cells
(Fig. 3B). Both adhesion to and invasion of HeLa cells were re-
stored by pBBRbtaE, confirming that the absence of btaE was re-
sponsible for the observed in vivo phenotypes. In order to deter-
mine if the diminished invasion was a consequence of the
reduction in adherence or, alternatively, was due to a reduced
invasion aptitude, the invasive cell/adherent cell ratio was calcu-
lated. As shown in Fig. 3C, the wild-type and mutant strains
showed similar efficiencies of invasion, suggesting that BtaE is
involved in the initial attachment of B. suis to HeLa cells rather
than in host cell internalization. To further investigate the ability
of the B. suis btaE mutant to attach to HeLa cells, a competitive
infection assay was carried out by coinoculating equal amounts of
B. suiswild-type andbtaE bacteria into theHeLa cell monolayer.
FIG 3 Adhesion to and invasion of HeLa cells. Approximately 5  106 bacteria were used to challenge 5  104 HeLa cells (MOI, 100:1). Total numbers of
adherent bacteria (A) and intracellular or invasive bacteria (B) were determined, and the invasive cell/adherent cell ratio was calculated (C). Total numbers of
adherent and intracellular bacteria are expressed relative to wild-type B. suis 1330, defined as 100%. (D) A competitive assay was carried out in which HeLa cells
were coinoculated with wild-type and B. suis btaE bacteria. The number of adherent bacteria was expressed as CFU/ml. (E) Inhibition of bacterial binding to
HeLa cells by preincubation with hyaluronic acid (HA); data are expressed as total CFU/ml. Values represent the means SD of the results of an experiment
representative of three independent assays done in triplicate or quadruplicate. Data were analyzed by one-way ANOVA followed by a Tukey a posteriori test. *,
significantly different from the wild type (P 0.05).
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TheBtaE-defectivemutantwas strongly outcompeted by thewild-
type strain for adhesion to HeLa (Fig. 3D), thus reinforcing the
idea that BtaE participates in the binding of B. suis to these cells.
We also investigated whether hyaluronic acid is able to com-
pete the binding of B. suis to HeLa cells. We found that preincu-
bation of wild-type bacteria with 25 g/ml hyaluronic acid inhib-
ited the binding to these cells by about 60%. In contrast, the
binding of the btaE mutant was inhibited only slightly by hyal-
uronic acid (Fig. 3E). This observation provides further evidence
that BtaE is involved in the binding of Brucella to hyaluronic acid.
To further investigate the in vivo adhesive phenotype of the
btaE mutant, the A549 epithelial cell line from human lung was
used as an alternative cellular model in the binding assay (39). B.
suis btaE showed a significant reduction in the ability to adhere
to (by 50% 8%) and invade (by 51% 13%) A549 cells com-
pared with the wild type (considered 100%) (Fig. 4A and B). As
predicted, the pBBRbtaE plasmid restored adhesion and invasion
capacity to wild-type levels in the B. suisbtaEmutant. Similar to
the phenotypes inHeLa cells, our data indicate that the decrease in
the invasion capacity ofB. suisbtaEwas a consequence of a lower
adhesion to A549 cells (Fig. 4C).
To test the possibility that BtaE could participate in later steps
of host cell infection, such as intracellular survival, a classical in-
tracellular proliferation assay was carried out, using murine J774
macrophages and HeLa cells. In both cell models, the wild-type
and mutant strains showed the same kinetics of intracellular rep-
lication (data not shown), indicating that the absence of BtaE does
not affect later stages of cellular infection.
To evaluate the contribution of BtaE to the virulence of B. suis,
we used themouse infectionmodel. Since it is possible that BtaE is
involved in the initial stages of infection, we decided to inoculate
mice through the intragastric route (40) and evaluate splenic in-
fection at different times postinfection (p.i.). It was previously
reported that the bacterial load in spleens andother organs ofmice
infected with B. abortus through the digestive track significantly
increases at 7 days p.i. and stabilizes at later times (41). Therefore,
we analyzed the spleen load after 7 and 30 days p.i. The B. suis
btaE mutant and the complemented (B. suis btaE pBBRbtaE)
and parental strains were administered intragastrically to mice,
and CFU counts in spleens were determined. At 7 and 30 days p.i.,
the splenic infection by the B. suis btaEmutant was significantly
reduced by 0.76 log and 1.24 log, respectively, compared with
infection by the parental wild-type strain (Fig. 5A and B). As pre-
dicted, the complemented strain harboring the pBBRbtaEplasmid
showed a splenic CFU count similar to that of the wild type. These
results show that BtaE is required for full virulence of B. suis in
mice infected through the oral route.
BtaE has a surface-exposed unipolar localization. While the
passenger domains of monomeric autotransporters may be
cleaved after secretion, the passenger domains of characterized
TAs remain intact after secretion (33). A recombinant peptide
corresponding to a portion of the passenger domain (see Fig. 1,
underlined region)was cloned, expressed inE. coli, and purified to
generate polyclonal anti-BtaE antibodies in mice. To evaluate the
membrane association of BtaE, Western blot analysis of whole
membranes from the B. suis wild-type or btaE mutant strain
obtained from exponential-phase cells was performed. Similar to
other TAs (42, 43), we noted that BtaE is difficult to denature. It was
suggested that the C-terminal domains of TAs form heat- and so-
dium dodecyl sulfate (SDS)-resistant trimers. Hence, the samples
were submitted to a strong denaturing process in the presence of
formic acid and resolved by SDS-PAGE.Western blot analysis using
the anti-BtaE antibodies showed thepresenceof an	75-kDaprotein
band corresponding to monomeric BtaE, which was absent in the
membrane fraction of the B. suisbtaE strain (Fig. 6A).
To assess the surface presentation of BtaE, late-exponential-
phase cultures of the B. suiswild-type orbtaE strain labeled with
green fluorescent protein (GFP) were refreshed for 1 h in TSB
medium and then fixed without permeabilization, incubated with
anti-BtaE antibodies, and observed by confocal microscopy. Un-
der the conditions assayed, we found that BtaEwas detected in 1%
to 3%of bacteria examined, but in all cases (n 50), the red signal
corresponding to BtaE exhibited unipolar localization (Fig. 6B).
As expected, no red signal was observed on the surface of the B.
suis btaE mutant but the unipolar signal was restored in the
complemented strain harboring the pBBRbtaE plasmid (data not
FIG 4 Adhesion to and invasion of A549 lung epithelial cells. Approximately 5  106 bacteria were used to challenge 5  104 A549 cells (MOI, 100:1). Total
numbers of adherent bacteria (A) and intracellular bacteria (B) were determined, and the invasive cell/adherent cell ratio was calculated (C). Total numbers of
adherent and intracellular bacteria are expressed relative to the adhesion and invasion values of the wild type, defined as 100%. Values represent themeans SD
of the results of an experiment representative of three independent assays done in triplicate. Data were analyzed by one-wayANOVA and a Tukey a posteriori test.
*, significantly different from the wild type (P 0.05).
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shown). To our knowledge, this is the first description of aTAwith
unipolar localization.
We also evaluated the BtaE localization in the E. coli heterolo-
gous host, carrying the pBBRbtaE plasmid. Western blot analysis
indicated the presence of the 75-kDa protein corresponding to
BtaE in the total membrane fraction of E. coli pBBRbtaE, which
was absent in the control strain (Fig. 6C). Interestingly, immuno-
fluorescence analysis of GFP-tagged E. coli carrying pBBRbtaE
showed BtaE foci at one bacterial pole in 5% of bacteria examined
(Fig. 6D), while no signal was observed in the control strain (data
not shown). This observation suggests that the mechanism in-
volved in polar targeting of the BtaE trimeric autotransporter is
conserved in E. coli.
Brucella’s new pole is functionally differentiated for adhe-
sion. Brucellae are proposed to be polarized bacteria, exhibiting
asymmetric division (44) and unipolar growth, as seen with sev-
eral other Rhizobiales (45). Moreover, proteins specifically re-
cruited to the old pole or to the new pole have been reported. The
PdhS histidine kinase is recruited to the old pole (19, 20), and the
putative DNA repair protein AidB is recruited to the new pole
(18). Since both the BmaC and BtaE adhesins showed unipolar
localization, the question arises as whether these adhesins are lo-
calized at a specific pole and, in that case, if they are localized at the
same pole. Therefore, to assess the relative localizations of BmaC
and BtaE, we used the PdhS and AidB proteins as markers of the
old and new poles, respectively.
Since the PdhS and AidB pole markers were identified in B.
abortus, we first evaluated the localization of the BmaC homo-
logue of B. abortus, which is 99.6% identical to BmaC from B. suis.
By immunofluorescence, it was confirmed that in B. abortus the
BmaC homologue consistently displays unipolar localization
(data not shown). Next, we used the B. abortus strains carrying the
FIG 5 Role of BtaE in the virulence of B. suis in BALB/c mice. BALB/c mice (10 mice per group) were inoculated by intragastric delivery of the B. suis wild type,
B. suis btaE, or the complemented strains. Five mice from each group were sacrificed at 7 (A) and 30 (B) days postinfection, and then spleens were removed.
Dilutions of spleen homogenates were plated in duplicate, and CFUwere counted and expressed as the log10 value per spleen. The CFU data were normalized by
log transformation and evaluated by one-way ANOVA followed by Dunnett’s a posteriori test. The experiment was repeated twice with similar results. *,
significantly different from the wild type (P 0.05).
FIG 6 BtaE localization. (A and C) Western blot analysis of whole-membrane fractions from B. suis (A) and E. coli pBBRbtaE (C) was carried out. Membrane
sampleswere submitted to a strong denaturing process. Sampleswere electrophoresed by SDS-PAGE and transferred to a PDVFmembrane. Blots were incubated
with anti-BtaE antisera and with anti-mouse HRP-conjugated secondary antibody and finally revealed using ECL Plus. On the right, a Coomassie blue pattern
is shown as a loading control (ctrl). (B andD)Detection of BtaE (in red) on theB. suis surface (B) and on theE. colipBBRbtaE surface (D) by immunofluorescence
of GFP-tagged bacteria. Cultures of GFP-labeled strains were fixed, incubated with anti-BtaE antibodies, and then probed with a CY3-conjugated donkey
anti-mouse antibody preparation. Samples were observed with a Plan-Aprochromat 100/1.4 oil DIC objective on a Zeiss LSM 5 Pascal confocal microscope.
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fusion proteins encoded by either pdhS-egfp (19) or aidB-yfp (18)
to evaluate by immunofluorescence the relative localization of
BmaC. DAPI staining and phase contrast were used to distinguish
the bacterial shapes. Analysis by confocal microscopy showed that
every time BmaC was detected (red signal) on the surface of B.
abortus carrying PdhS-eGFP protein (green), it was at the pole
opposite PdhS-eGFP (29 occurrences) (Fig. 7A). It was never ob-
served that BmaC and PdhS-eGFP colocalized. Conversely, every
time BmaC was detected in the strain carrying the AidB-YFP pro-
tein (yellow), it was either at the same pole as the AidB-YFP
marker (31 occurrences) or in cells with diffusemarkers, but never
at the opposite pole (Fig. 7B). As expected, a bmaC mutant of B.
abortus did not show any red signal (data not shown).
The pdhS-egfp and aidB-yfp fusions were introduced into the
wild-type strain of B. suis and also into the isogenic B. suisbmaC
mutant as a negative control. The same analysis described above
was carried out with these strains, leading to the same conclusion;
i.e., BmaC is localized at the new pole of B. suis (data not shown).
We next analyzed the relative localization of BtaE in B. suis. We
found that every timeBtaEwas detected on bacteria expressing the
old pole marker (PdhS-eGFP), it was at the opposite pole (30
occurrences) (Fig. 7C), but it was never observed at the same pole
as PdhS-eGFP. Instead, in all the cases where BtaE was detected in
bacteria carrying the aidB-yfp fusion, it was observed either at the
same pole as the AidB-YFP fusion (17 occurrences) or in bacteria
in which this marker was diffuse, but on no occasion was the BtaE
fluorescent focus at the opposite pole (Fig. 7D). Taken together,
our results show that under the conditions tested here both the
BmaC and BtaE adhesins are localized at the new pole, suggesting
that this pole is functionally differentiated for adhesion.
DISCUSSION
In microbial pathogens, adhesion to host cells is a critical step in
the infection process. The importance of adhesion is reflected by
the finding that several bacterial pathogens display multiple ad-
hesins, which can act synergistically, thereby enhancing their ad-
hesive capacity. Despite the relevance of adhesion in the interac-
tion with the host, the impact of this step in Brucella pathogenesis
was little explored.We presented evidence indicating that themo-
nomeric BmaC autotransporter is required for an efficient adhe-
sion of B. suis to host cells (15). In this work, we aimed to explore
the role of BtaE, a protein that is predicted to belong to the TA
family, in the interaction of B. suis with the host. Since it is ex-
pected that pathogens harbor several adhesins, probably exhibit-
ing overlapping functions, we initially assessed the function of
BtaE using a heterologous approach and found that this protein
was able to increase the affinity of a “nonadherent” E. coli strain to
immobilized hyaluronic acid and fibronectin. Analysis of the
knockout btaE mutant confirmed the role of BtaE in the binding
of B. suis to one of these ECM components, the hyaluronic acid
glycosaminoglycan. The possibility exists that a fibronectin-bind-
ing-defective phenotype can be masked by other fibronectin-
binding proteins, such as BmaC (15). The ability of BtaE to medi-
ate the binding of Brucella to hyaluronic acid may be relevant at
different stages of the infection. For example, it could facilitate
initial bacterial adhesion to epithelial cells. It was previously de-
scribed that hyaluronic acid is involved in adhesion of other
pathogens such asMycobacterium tuberculosis to the human lung
epithelial cell line A549 (46), a cell type to which Brucella also
adheres (47). Indeed, binding assays demonstrated that BtaE con-
tributes to the adhesion of B. suis to both A549 and HeLa cells.
Interestingly, addition of hyaluronic acid was able to compete the
binding of the wild-type strain toHeLa cells, while adhesion of the
btaE mutant was inhibited only slightly by hyaluronic acid. This
observation provides further evidence that BtaE mediates the
binding of Brucella to hyaluronic acid. Furthermore, taken to-
gether, our observations are consistent with the possibility that
BtaE mediates adhesion to cells, at least in part, through hyal-
uronic acid. As hyaluronic acid is a component of the ECM of
several tissues, BtaE could also be involved in Brucella dissemina-
tion to different target tissues such as cartilage, heart, and bone,
which may result in serious complications of brucellosis.
The role of BtaE in the virulence of B. suis was studied by
inoculating the wild type, the btaE deletion mutant, and the com-
plementing strain inmice through the oral route. At 7 and 30 days
p.i., splenic infection by B. suis btaE was significantly reduced,
compared to infection by the wild type, while the complemented
strain showed a restored phenotype. This result strongly suggests
that the BtaE adhesin might be considered a virulence factor and
highlights the importance of bacterial adhesion to host compo-
nents during the Brucella infection process.
Immunofluorescence analysis showed that BtaE exhibits uni-
polar localization. To the best of our knowledge, this is the first
report of unipolar localization for a TA. Yet several monomeric
(type I) autotransporters from rod-shaped pathogens, including
the BmaC adhesin of B. suis (15), the IcsA protein from Shigella
flexneri (48), and the AIDA-I monomeric autotransporter that
mediates adhesion to human cells by pathogenic diffusely adher-
ent E. coli (DAEC) strains (49), were shown to localize at one
bacterial pole. It was reported that IcsA localizes to the pole at
which actin assembly occurs, which is the old pole (48). Remark-
ably, some of the paradigmatic type I autotransporters, including
AIDA-I and IcsA, are polar in the cytoplasm prior to secretion,
suggesting that secretion occurs at the pole (49, 50). Intriguingly,
it was shown that NalP, a monomeric autotransporter of spheri-
cally shaped Neisseria meningitidis, contains the molecular infor-
mation to localize to the pole of E. coli. In fact, the BtaE TA also
showed unipolar localization in the E. coli heterologous host, sup-
porting the notion that the polar targetingmechanism of proteins
from the autotransporter families is conserved in several bacteria.
The observation that both BtaE and BmaC show unipolar lo-
calization prompted us to explore whether they are associated
with a specific (new or old) pole and, if this is the case, whether
they are at the same or a different one. Evidence presented by
others and us indicates that the individual Brucella bacterium in-
teracts with the host cell surface through one of its poles (15, 51).
Furthermore, it seems that the pole where BmaC is located on
single bacteria is the one that interacts with the cell surface (15).
Therefore, it was also interesting to address the issue as to which
could be the “adhesive” pole. To determine the pole where the
adhesins localize, we used the PdhS-eGFP fusion as amarker of the
old pole (19), and theAidB-YFP fusion as amarker of the newpole
(18). We observed that every time BmaC or BtaE was detected, it
localized to the pole opposite the pole where PdhS-eGFP was lo-
cated. In contrast, on every occasion that the BmaC or BtaE fluo-
rescent foci were observed in bacteria expressing the new pole
fusion, they were found at the same pole as AidB-YFP. We con-
clude that under the conditions tested here, both BmaC and BtaE
localize to the new pole generated after cell division. Accordingly,
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FIG7 BtaE and BmaC are localized to the new bacterial pole. (A and B) Immunofluorescencemicroscopy using anti-BmaC antibodies was carried out with fixed
cultures ofB. abortus strains expressing PdhS-eGFP (A) andAidB-YFP (B) as old and newpolemarkers, respectively. DAPI staining and phase contrast (PC)were
used to visualize the bacterial DNA content and shape, respectively. Samples were observed with a confocal LSM 510Metamicroscope using a Plan-Apochromat
60/1.4 oil DIC objective. Representative images are shown. BmaC, PdhS-eGFP, and AidB-YFP are indicated with red, green, and yellow arrows, respectively.
A schematic representation is also displayed. An intensity profile of the channels (constructed through the cyan dotted arrow) is presented, expressed in arbitrary
units. (C and D) The same analysis was carried out for BtaE in B. suis with both PdhS-eGFP (C) and AidB-YFP (D).
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we propose that the new pole is functionally differentiated for
adhesion.
BtaE was detected in a low proportion of cells. A similar obser-
vation was previously made for the unipolar BmaC adhesin (15).
At present, we do not know the reason for these observations. One
possibility is that the level of btaE or bmaC gene transcription in
vitro is not high enough to allow detection of fluorescent foci in
most cells. If this is the case, an increase in btaE or bmaC expres-
sion is predicted to occur within the host environment before
bacterial internalization. Since the anti-BtaE and anti-BmaC an-
tibodies used in the immunofluorescence assays recognize a pep-
tide of the passenger domains, another nonexclusive explanation
is that these peptides are not very accessible to the antibodies in the
native -roll structure exposed on the bacterial surface (17). Fi-
nally, another interesting hypothesis is that BtaE and BmaC are
expressed only in a bacterial subpopulation. This possibility is
supported by the finding that several cell types generated by asym-
metric division and differentiation coexist in a culture of B. abor-
tus (19, 20, 44). Furthermore, relatively low expression of btaE or
bmaC in a small subpopulation of bacteria might be sufficient for
bacterial internalization and a successful (but limited) infection.
Further studies are required to explore these possibilities.
Several surface virulence factors (including adhesive struc-
tures) were found to exhibit polar localization in other alphapro-
teobacteria closely related toBrucella. It was reported that allAgro-
bacterium tumefaciens VirB proteins are polarly localized (52).
Furthermore, A. tumefaciens attaches efficiently to plant and abi-
otic surfaces through one of its poles in a process mediated by
several structures, including a unipolar polysaccharide (UPP)
(53). Very interestingly, evidence was presented indicating that
cells of A. tumefaciens preferentially attach to surfaces via the old
cell pole (45). Evidence presented in this work and other previ-
ously reported evidence (15) support the hypothesis that the un-
ipolar BmaC and BtaE adhesins mediate Brucella binding to host
cells at its new pole. It is possible that the characteristics of the
polar asymmetry depend on the bacterial life style. In the case ofA.
tumefaciens, a sessile or attached mode of life would require that
adhesion to abiotic or biotic surfaces is mediated by adhesins lo-
calized at the relatively stable old pole (53); in Brucella, initial
binding of single bacteria to host cells prior to cellular internaliza-
tion would be mediated by adhesins localized at the new pole of a
subpopulation of infective bacteria.
In addition to BmaC and BtaE, other putative adhesins were
shown to participate in the interaction of Brucella with the host.
Recently, it was reported that a pathogenicity island of four genes
contributes to the efficiency of attachment of B. abortus to both
HeLa and J774 macrophage cells. One of the proteins encoded by
the gene cluster was a hypothetical protein (Bab1_2009) that har-
bors an immunoglobulin-like BID_1 adhesion domain, found in
adhesins such as the E. coli intimin (13). In addition, it was previ-
ously reported that a predicted adhesin from the monomeric au-
totransporter family from B. suis (OmaA) would be important
during the chronic phase of infection (54). It will be interesting to
determine whether Bab1_2009, OmaA, BtaE, and BmaC play re-
dundant, synergistic, or complementary roles in the interaction of
Brucellawith different cell types and/or host tissues. Furthermore,
different adhesins could exert their roles at different infection
stages. Studies on gene regulation could give a hint regarding these
possibilities. Through a transcriptomic analysis, it was previously
shown that the expression of the btaE orthologue from B.meliten-
sis (BMEI1873) is reduced in a mutant defective in the LuxR ho-
mologue VjbR regulator (55), which modulates the expression of
transcripts required for intracellular survival (56). Besides, by mi-
croarray analysis it was found that transcription of the bmaC or-
thologue of B. abortus was downregulated by the BvrR/BvrS two-
component system. This system plays a role in the adjustment of
Brucella physiology to the shift expected to occur during the tran-
sition from the extracellular to the intracellular niche (57). Thus,
one plausible hypothesis is that btaE expression and bmaC expres-
sion are induced under different stimulus conditions. Future
studies will focus on the regulatory elements that control the ex-
pression of the autoransporter adhesins during the onset of cell
infection.
Not only surface proteins were shown to participate in the
adhesive properties of Brucella. Overexpression of an acyl homo-
serine-lactone (AHL) acylase (that degrades AHLs) inB.melitensis
induced clumping and increased adhesion to both polystyrene
and HeLa cells, probably due to the production of both some
polymeric substances and outer membrane vesicles (16). It was
argued that adhesion of the quorum-sensing-defective strain was
somehow reminiscent of the adherence of localized bacterial col-
onies of B. abortus to epithelial cells (12). Thus, it is possible that
initial and polar attachment of single bacteria to the host cell is
mediated by proteinaceous adhesins, such as BtaE or BmaC and
that, eventually, subsequent formation of bacterial microcolonies
would be promoted by the production of other polymeric sub-
stances induced in contact with the cell surface.
Finally, host tropism is a very important feature of the Brucella
genus, for which the concept of species is controversial, due to the
high degree of similarity between the Brucella genomes (58). For
example, comparison of the B. melitensis 16 M and B. suis 1330
genomes revealed extensive gene similarity and synteny, with the
majority (
90%) of genes sharing 98% to 100% identity (32, 59).
It is striking that most of the genes that were more variable were
genes encoding surface-exposed proteins, leading to the hypoth-
esis that they could contribute to differences in host preference
and disease manifestation (32). In addition to B. suis and B.
melitensis, we also found BtaE orthologues in B. abortus 2308
(BAB1_0069), B. canis ATCC 23365 (BCAN_A0073), B. ovis
25810 (BOV_0071), and B. microti CCM4915 (BMI_I75). Inter-
estingly, in silico analysis indicated that there are significant differ-
ences either in protein lengths or in the number of repetitive mo-
tifs between the different ortologues. Therefore, variations found
in BtaE and other adhesins such as BmaC (15)maywell contribute
to host preference or tissue tropism. It will be interesting, in the
future, to assess this hypothesis.
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